Sienna Biopharmaceuticals

SNNAQ

OTCHealth Care

Income Statement

Total Revenue$0

Gross Profit$0

Operating Income$-16.08M

EBITDA$-17.1M

EBIT$-17.18M

Pre-tax Income$-52.57M

Net Income$-7.94M

Net Cash$113.32M

Cash Equivalent$5.77M

Total Debt$6.87M

Net Debt$-106.45M

Book Value$11.55M

Net Cash Per Share3.68

Book Value Per Share0.75

Return on Equity (ROE)-276.40%

Return on Assets (ROA)-68.47%

Return on Invested Capital (ROI)-129.56%

Net Profit Marginundefined

Current Ratio2.07

Quick Ratio2.00

Long-Term Debt / Equity1.13